SPLITOAK STRATEGIES LLC for CARIS LIFE SCIENCES, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Continue access to molecular and advanced genomic testing via telehealth; HR 2407/S The Medicare Multi-Cancer Early Detection Screening Coverage Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN | Special Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy Analyst |
Medical/Disease Research/Clinical Labs MED
Ensuring access to advanced genomic testing for cancer; Providing an appropriate regulatory model for advanced genomic cancer testing; Use of real-world evidence in clinical trials and FDA review; Cancer Moonshot; FDA proposed regulation to provide oversight of diagnostic lab tests
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN | — |
Health Issues HCR
Providing an appropriate regulatory model for advanced genomic cancer testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.